Search Results: Life Science Venture Capital

 
Suggestion
SVB Capital
You rely on superior returns from your alternative investments. SVB Capital brings you the best in private venture investing.
Read More
Silicon Valley Bank wins ‘Service Provider of the Year’ at Investor Allstars Awards
London – 26 September 2013 - Silicon Valley Bank, financial partner to the technology, life sciences, cleantech, private equity and venture capital industries has been recognised as ‘Service Provider of the Year’ for the second year running at the prestigious Investor Allstars Awards, 2013.The event...
Read More
Silicon Valley Bank UK Strengthens Technology Banking Team with New Appointment
Silicon Valley Bank, financial partner to the technology, life science, private equity and venture capital industries today announced the appointment of Tom Butterworth as Vice President, Entrepreneur Commercial Banking for Silicon Valley Bank’s UK Branch.Tom has a strong background in banking techn...
Read More
Cleversafe Secures Financing from Silicon Valley Bank(2)
Silicon Valley Bank, the premier commercial bank for emerging, growth and mature companies in the technology, life science, venture capital/private equity and premium wine industries, is pleased to highlight a recent activity with our Midwest client, Cleversafe. Term Loan Line of Credit About Silico...
Read More
Silicon Valley Bank Provides Financing for Francisco Partners Acquisition of Kewill PLC
LONDON, UK - August 15th, 2012 - Silicon Valley Bank, financial partner to the technology, life science, cleantech, private equity and venture capital industries, today announced that it has provided Francisco Partners, a leading global technology-focused private equity firm, with senior debt financ...
Read More
Biotech Executive Series (1 of 3)
Biotech Executive Series (1 of 3)EY Bioscience Hub, Kendall Square, Boston, 1 Cambridge Center … Hanewich, Head of Healthcare and Life Sciences … Venture Capital will be moderating the upcoming Biotech Executive Series … of TESARO will discuss the current state of the biotech industry, capital … IPO window and recent outlook for biotech venture capital. Bryan and Mary Lynne will also explore …
Read More

Featured Commentary & Analysis


Analytics; Life Science
May 09, 2011 Posted by
Join our panel of experts on biopharma valuations and venture capital investment in this Web seminar as they discuss the results of SVB Analytics’ latest research findings, including operating performance, venture funding and valuations, and exit activity ...
Read More

Venture Capital
March 09, 2010 Posted by
In January 2010, four representatives from the Yangpu District Government of Shanghai arrived in the Bay Area for a three-month educational program at San Francisco State University. While in the Bay Area, they also attended programs with SVB Financial Group. The visit follows Silicon Valley Bank’s addition of a repre
Read More

Cleantech
June 03, 2010 Posted by
On April 8-9, 2010, Silicon Valley Bank broughttogether 104 experts from the entrepreneurial, venture capital, energy,academic and policy worlds to discuss critical issues affecting the long termgrowth of the energy generation, storage and efficiency markets.  Here are our key takeaways from this set ofinvigorating, closed door discussions.
Read More

Cleantech
April 09, 2010 Posted by
The magnitude of opportunities in global energy markets is enormous, but scaling up a new technology to “utility” scale also presents unique challenges for the venture model. The leap from initial product demonstration and small scale manufacturing into production or assets in the hundreds of megawatts (and hundreds of millions of dollars) largely exceeds the capacity of venture equity financing. Given the current state of capital markets, start-ups are wondering what sources of lending are available for initial large scale manufacturing or projects and what role can and should government play (for example, through loan guarantees and grants) in “picking winners” and lowering the hurdle for new clean energy technologies to attract commercial capital and gain traction in the market.
Read More

Life Science
May 18, 2011 Posted by
Having worked with life science companies for many years, we recognized that the M&A data that was available in the market was too inclusive. We started looking at the data ourselves, in a slightly different way and discovered some really interesting findings that surprised us.
Read More
Client Services

Online Banking Services/
Help Desk

North America
clientservice@svb.com
1.800.774.7390 | 1.408.654.4636
5:00 a.m. – 5:30 p.m. Pacific Time
(Monday - Friday)

United Kingdom
ukclientservice@svb.com
0800.023.1441 (toll free) | 0207.367.7881
8:00 a.m. – 1:30 a.m GMT

Check Verification

Verify a check issued from
SVB client's account
1.408.654.5570
svbfmo@svb.com

Audit Requests

Audit Confirmation Requests
www.confirmation.com

Commercial Cards

Cards Issued in North America

Lost or Stolen Cards
1.866.563.1335
001.408.654.1039 International

Card Services
1.866.553.3481
001.408.654.1039 International
cardoperations@svb.com

Cards Issued in United Kingdom

Lost, stolen, fraud, and general enquiries
0800.023.1450 from within the UK
+44.0.207.367.7899 from overseas

Current Day Information Reporting

See Current-day Information Reporting on SVB Online Banking

• Check print: 8:00 p.m. Pacific Time
• Check to ACH: 7:00 p.m. Pacific Time  for next day check print/ACH
• Virtual card numbers: Real-time processing

Holiday Schedule

SVB Holiday Schedule
– U.S. (Federal) and U.K. (Bank of England) holiday schedule

Private Bank Help

Email: privatebank@svb.com
U.S. Domestic: 1.866.238.0872
International: 001.650.926.0499

Contact your relationship manager

Wire Transfer Instructions

Obtain Credit Reference

Obtain credit reference for
SVB clients

Fax 1.408.654.6234
CreditRatings@svb.com

SVB Investments

SVB Securities
1.800.303.7371 | 1.408.654.7367
service@svbsecurities.com

SVB Repo
1.800.303.7371 | 1.408.654.7367
cmgrepo@svb.com

SVB Asset Management
1.866.719.9117
sampagroup@svb.com

Transaction Cutoff Times

Find the cutoff times for incoming and outgoing wires, payments, investment and internal transfers, and other activities.